70585-52-3 Usage
General Description
6-nitroquinoline-8-carboxylic acid is a chemical compound with the molecular formula C10H6N2O4. It is a yellow crystalline solid that is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 6-nitroquinoline-8-carboxylic acid has been found to exhibit antimicrobial and antifungal properties, and it has been studied for its potential use in the treatment of various bacterial infections. It is also used as a building block in the synthesis of various organic compounds, and its versatile reactivity makes it a valuable tool in the field of organic chemistry. Additionally, 6-nitroquinoline-8-carboxylic acid has been investigated for its potential as a fluorescent probe for detecting metal ions in biological systems. Overall, this compound has a wide range of potential applications in the fields of medicine, agriculture, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 70585-52-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,5,8 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70585-52:
(7*7)+(6*0)+(5*5)+(4*8)+(3*5)+(2*5)+(1*2)=133
133 % 10 = 3
So 70585-52-3 is a valid CAS Registry Number.
70585-52-3Relevant articles and documents
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
